Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2

Vet Microbiol. 2013 Apr 12;163(1-2):177-83. doi: 10.1016/j.vetmic.2012.12.019. Epub 2012 Dec 22.

Abstract

Porcine circovirus (PCV) type 2b (PCV2b) emerged in North America in 2005-2006. During May of 2012, PCVAD occurred in 10-18-week-old pigs in two farms within a production system that routinely vaccinated against PCV2. Both farms received replacement gilts from the same multiplier. A mutant PCV2b strain not previously present in North America was identified. The strain was found to be 99.9% identical to a recently described mutant PCV2 isolate reported in China in 2010 and thought to be more virulent than classical PCV2a or PCV2b strains. It is possible that the current PCV2a-based commercial vaccines are not fully protective against this new strain. In addition, emerging porcine parvovirus type 2 (PPV2) was detected in 55% of the serum samples (73/132), perhaps implying that PPV2 could be a cofactor in cases of PCVAD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Base Sequence
  • China
  • Circoviridae Infections / complications
  • Circoviridae Infections / immunology
  • Circoviridae Infections / veterinary*
  • Circoviridae Infections / virology
  • Circovirus / genetics
  • Circovirus / immunology
  • Circovirus / isolation & purification
  • Circovirus / pathogenicity
  • Genes, Viral / genetics
  • Molecular Sequence Data
  • Parvoviridae Infections / complications
  • Parvoviridae Infections / veterinary*
  • Parvoviridae Infections / virology
  • Parvovirus, Porcine / genetics
  • Sequence Alignment
  • Swine
  • Swine Diseases / immunology
  • Swine Diseases / prevention & control
  • Swine Diseases / virology*
  • United States
  • Viral Vaccines / standards

Substances

  • Antibodies, Viral
  • Viral Vaccines